Annual Accounts Receivable
$56.87 M
+$8.72 M+18.10%
31 December 2021
Summary:
BioDelivery Sciences International annual accounts receivable is currently $56.87 million, with the most recent change of +$8.72 million (+18.10%) on 31 December 2021. During the last 3 years, it has risen by +$8.72 million (+18.10%).BDSI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$56.87 M
-$705.00 K-1.22%
31 December 2021
Summary:
BioDelivery Sciences International quarterly accounts receivable is currently $56.87 million, with the most recent change of -$705.00 thousand (-1.22%) on 31 December 2021.BDSI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDSI Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +18.1% | -1.2% |
| 5 y5 years | +317.3% | +70.2% |
BDSI Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -1.2% |
BioDelivery Sciences International Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $56.87 M(+18.1%) | $56.87 M(-1.2%) |
| Sept 2021 | - | $57.57 M(+8.9%) |
| June 2021 | - | $52.87 M(+9.5%) |
| Mar 2021 | - | $48.29 M(+0.3%) |
| Dec 2020 | $48.15 M(+24.1%) | $48.15 M(+9.9%) |
| Sept 2020 | - | $43.83 M(-8.9%) |
| June 2020 | - | $48.13 M(+6.7%) |
| Mar 2020 | - | $45.11 M(+16.3%) |
| Dec 2019 | $38.79 M(+184.7%) | $38.79 M(+16.1%) |
| Sept 2019 | - | $33.42 M(+34.3%) |
| June 2019 | - | $24.88 M(+55.4%) |
| Mar 2019 | - | $16.01 M(+17.5%) |
| Dec 2018 | $13.63 M(+53.9%) | $13.63 M(+8.4%) |
| Sept 2018 | - | $12.57 M(+33.6%) |
| June 2018 | - | $9.41 M(+15.8%) |
| Mar 2018 | - | $8.12 M(-8.2%) |
| Dec 2017 | $8.85 M(+198.3%) | $8.85 M(-18.0%) |
| Sept 2017 | - | $10.79 M(+39.2%) |
| June 2017 | - | $7.75 M(+9.2%) |
| Mar 2017 | - | $7.10 M(+139.4%) |
| Dec 2016 | $2.97 M(+19.3%) | $2.97 M(-3.9%) |
| Sept 2016 | - | $3.09 M(+28.3%) |
| June 2016 | - | $2.41 M(+12.9%) |
| Mar 2016 | - | $2.13 M(-14.3%) |
| Dec 2015 | $2.49 M(-20.8%) | $2.49 M(+77.0%) |
| Sept 2015 | - | $1.41 M(-7.9%) |
| June 2015 | - | $1.53 M(-49.7%) |
| Mar 2015 | - | $3.03 M(-3.5%) |
| Dec 2014 | $3.14 M(+12.4%) | $3.14 M(+1430.7%) |
| Sept 2014 | - | $205.20 K(-98.4%) |
| June 2014 | - | $12.64 M(+399.3%) |
| Mar 2014 | - | $2.53 M(-9.4%) |
| Dec 2013 | $2.79 M(+436.5%) | $2.79 M(+215.6%) |
| Sept 2013 | - | $885.40 K(+73.9%) |
| June 2013 | - | $509.00 K(+123.6%) |
| Mar 2013 | - | $227.60 K(-56.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $520.80 K(+415.1%) | $520.80 K(+2043.2%) |
| Sept 2012 | - | $24.30 K(+5.2%) |
| June 2012 | - | $23.10 K(-88.3%) |
| Mar 2012 | - | $197.70 K(+95.5%) |
| Dec 2011 | $101.10 K(-84.0%) | $101.10 K(-93.9%) |
| Sept 2011 | - | $1.65 M(+643.3%) |
| June 2011 | - | $222.60 K(-70.0%) |
| Mar 2011 | - | $741.30 K(+17.1%) |
| Dec 2010 | $633.20 K(-50.1%) | $633.20 K(+9.4%) |
| Sept 2010 | - | $578.90 K(-43.2%) |
| June 2010 | - | $1.02 M(+118.5%) |
| Mar 2010 | - | $466.40 K(-63.2%) |
| Dec 2009 | $1.27 M(+170.5%) | $1.27 M(+13.6%) |
| Sept 2009 | - | $1.12 M(+55.6%) |
| June 2009 | - | $717.70 K(+47.3%) |
| Mar 2009 | - | $487.20 K(+3.9%) |
| Dec 2008 | $469.00 K(+53.5%) | $469.00 K(+46.9%) |
| Sept 2008 | - | $319.20 K(-2.3%) |
| June 2008 | - | $326.70 K(+40.3%) |
| Mar 2008 | - | $232.90 K(-23.8%) |
| Dec 2007 | $305.50 K(+625.7%) | $305.50 K(+1964.2%) |
| Sept 2007 | - | $14.80 K(-2.6%) |
| June 2007 | - | $15.20 K(-63.0%) |
| Mar 2007 | - | $41.10 K(-2.4%) |
| Dec 2006 | $42.10 K(+55.4%) | $42.10 K(-43.9%) |
| Sept 2006 | - | $75.00 K(+133.6%) |
| Sept 2005 | - | $32.10 K(+5.9%) |
| June 2005 | - | $30.30 K(+0.3%) |
| Mar 2005 | - | $30.20 K(+11.4%) |
| Dec 2004 | $27.10 K(-98.6%) | $27.10 K(-94.9%) |
| Sept 2004 | - | $527.10 K(+1845.0%) |
| June 2004 | - | $27.10 K(+15.3%) |
| Mar 2004 | - | $23.50 K(+370.0%) |
| Mar 2003 | - | $5000.00(-99.8%) |
| Dec 2002 | $2.00 M(>+9900.0%) | $2.00 M(+298.6%) |
| June 2002 | - | $501.70 K(>+9900.0%) |
| Dec 2001 | $0.00 | $0.00 |
FAQ
- What is BioDelivery Sciences International annual accounts receivable?
- What is the all time high annual accounts receivable for BioDelivery Sciences International?
- What is BioDelivery Sciences International quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for BioDelivery Sciences International?
What is BioDelivery Sciences International annual accounts receivable?
The current annual accounts receivable of BDSI is $56.87 M
What is the all time high annual accounts receivable for BioDelivery Sciences International?
BioDelivery Sciences International all-time high annual accounts receivable is $56.87 M
What is BioDelivery Sciences International quarterly accounts receivable?
The current quarterly accounts receivable of BDSI is $56.87 M
What is the all time high quarterly accounts receivable for BioDelivery Sciences International?
BioDelivery Sciences International all-time high quarterly accounts receivable is $57.57 M